Atopic dermatitis (AD) is a common skin disease, associated with high burden impact in quality of live, in moderate-severe disease severity. Several targeted drugs are under development for AD. Here, we present a patient with refractory disease to systemic traditional immunosuppressive drugs, treated successfully with oral tofacitinib, with complete response.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752607 | PMC |
| http://dx.doi.org/10.1002/ccr3.3325 | DOI Listing |
Publication Analysis
Top Keywords
atopic dermatitis
8
refractory disease
8
dermatitis tofacitinib
4
tofacitinib option
4
option refractory
4
disease
4
disease atopic
4
dermatitis common
4
common skin
4
skin disease
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!